name: 'exosome-ev-analysis-agent'
description: 'AI-powered extracellular vesicle and exosome analysis for cancer biomarker discovery, liquid biopsy applications, and intercellular communication profiling.'
measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes.
allowed-tools:
- read_file
- run_shell_command
Exosome/EV Analysis Agent
The Exosome/EV Analysis Agent provides comprehensive AI-driven analysis of extracellular vesicles for cancer biomarker discovery, liquid biopsy applications, and tumor-microenvironment communication profiling.
When to Use This Skill
- When analyzing exosome cargo (RNA, protein, lipids) for biomarker discovery.
- To identify tumor-derived EVs in liquid biopsy samples.
- For profiling EV-mediated intercellular communication in cancer.
- When predicting EV uptake and functional effects on recipient cells.
- To design EV-based diagnostic or therapeutic applications.
Core Capabilities
EV Cargo Profiling: Analyze exosomal RNA (miRNA, lncRNA, circRNA), proteins, and lipids.
Tumor EV Identification: Distinguish tumor-derived EVs from normal EVs using surface markers and cargo.
Biomarker Discovery: ML-driven identification of cancer-specific EV signatures.
Communication Network: Map EV-mediated signaling between tumor and TME cells.
Functional Prediction: Predict downstream effects of EV cargo on recipient cells.
Diagnostic Development: Support EV-based diagnostic assay design.
EV Classification
| Type |
Size |
Origin |
Markers |
| Exosomes |
30-150 nm |
MVB fusion |
CD9, CD63, CD81 |
| Microvesicles |
100-1000 nm |
Membrane budding |
Annexin V, ARF6 |
| Apoptotic bodies |
500-5000 nm |
Cell death |
Annexin V, PS |
| Large oncosomes |
1-10 μm |
Tumor-specific |
Variable |
Workflow
Input: EV isolation method, cargo profiling data (RNA-seq, proteomics), characterization data.
Quality Assessment: Evaluate EV purity and characterization (NTA, TEM, markers).
Cargo Analysis: Profile RNA, protein, and lipid content.
Source Deconvolution: Identify tumor vs stromal EV origin.
Biomarker Selection: Identify cancer-specific signatures.
Functional Prediction: Predict effects on recipient cells.
Output: EV profile, biomarker candidates, functional predictions.
Example Usage
User: "Analyze exosomal miRNA profiles from plasma samples to identify pancreatic cancer biomarkers."
Agent Action:
python3 Skills/Oncology/Exosome_EV_Analysis_Agent/ev_analyzer.py \
--ev_mirna exosome_smallrna.tsv \
--ev_protein exosome_proteome.tsv \
--sample_groups pancreatic_cancer,healthy \
--normalization spike_in \
--biomarker_discovery true \
--output ev_biomarker_report/
Exosomal miRNA Cancer Biomarkers
| Cancer Type |
Elevated miRNAs |
Clinical Use |
| Pancreatic |
miR-21, miR-17-5p, miR-155 |
Early detection |
| Lung |
miR-21, miR-126, miR-210 |
Screening |
| Colorectal |
miR-21, miR-92a, miR-29a |
Detection |
| Prostate |
miR-141, miR-375, miR-1290 |
Prognosis |
| Ovarian |
miR-21, miR-141, miR-200 family |
Detection |
| Breast |
miR-21, miR-155, miR-10b |
Metastasis |
EV Isolation Methods
| Method |
Principle |
Purity |
Yield |
Scalability |
| Ultracentrifugation |
Density |
Moderate |
High |
Low |
| Size exclusion |
Size |
High |
Moderate |
Moderate |
| Immunocapture |
Surface markers |
Very high |
Low |
Low |
| Precipitation |
Polymer |
Low |
Very high |
High |
| Microfluidics |
Various |
Variable |
Low |
Low |
AI/ML Components
Biomarker Discovery:
- Differential expression analysis
- Machine learning feature selection
- Multi-marker panel optimization
- Cross-validation and independent validation
Source Deconvolution:
- Marker-based classification
- ML models for tumor vs normal EVs
- Cell-type specific cargo signatures
Functional Prediction:
- miRNA target prediction
- Pathway enrichment
- Recipient cell effect modeling
EV Characterization Quality
MISEV Guidelines Requirements:
- Particle concentration (NTA/TRPS)
- Size distribution (NTA/DLS/TEM)
- Protein markers (CD9/63/81, TSG101, ALIX)
- Negative markers (calnexin, albumin)
- Morphology (TEM)
Clinical Applications
- Early Detection: Cancer screening from blood EVs
- Prognosis: EV signatures predicting outcomes
- Therapy Response: Monitor treatment effect
- Metastasis: Predict metastatic potential
- Resistance: Identify resistance mechanisms
Prerequisites
- Python 3.10+
- Small RNA analysis tools
- Proteomics analysis packages
- ML frameworks (scikit-learn, XGBoost)
Related Skills
- Liquid_Biopsy_Analytics_Agent - For other liquid biopsy analytes
- Tumor_Microenvironment - For TME communication
- Cell-Free RNA Analysis - For plasma RNA
Emerging Applications
- EV-based Drug Delivery: Therapeutic cargo loading
- EV Engineering: Surface modification for targeting
- Tumor Vaccines: EV-based immunotherapy
- Companion Diagnostics: Treatment selection markers
Author
AI Group - Biomedical AI Platform
1---2name: exosome-ev-analysis-agent3description: <!--4---5<!--6# COPYRIGHT NOTICE7# This file is part of the "Universal Biomedical Skills" project.8# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>9# All Rights Reserved.10#11# This code is proprietary and confidential.12# Unauthorized copying of this file, via any medium is strictly prohibited.13#14# Provenance: Authenticated by MD BABU MIA1516-->1718---19name: 'exosome-ev-analysis-agent'20description: 'AI-powered extracellular vesicle and exosome analysis for cancer biomarker discovery, liquid biopsy applications, and intercellular communication profiling.'21measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes.22allowed-tools:23 - read_file24 - run_shell_command25---262728# Exosome/EV Analysis Agent2930The **Exosome/EV Analysis Agent** provides comprehensive AI-driven analysis of extracellular vesicles for cancer biomarker discovery, liquid biopsy applications, and tumor-microenvironment communication profiling.3132## When to Use This Skill3334* When analyzing exosome cargo (RNA, protein, lipids) for biomarker discovery.35* To identify tumor-derived EVs in liquid biopsy samples.36* For profiling EV-mediated intercellular communication in cancer.37* When predicting EV uptake and functional effects on recipient cells.38* To design EV-based diagnostic or therapeutic applications.3940## Core Capabilities41421. **EV Cargo Profiling**: Analyze exosomal RNA (miRNA, lncRNA, circRNA), proteins, and lipids.43442. **Tumor EV Identification**: Distinguish tumor-derived EVs from normal EVs using surface markers and cargo.45463. **Biomarker Discovery**: ML-driven identification of cancer-specific EV signatures.47484. **Communication Network**: Map EV-mediated signaling between tumor and TME cells.49505. **Functional Prediction**: Predict downstream effects of EV cargo on recipient cells.51526. **Diagnostic Development**: Support EV-based diagnostic assay design.5354## EV Classification5556| Type | Size | Origin | Markers |57|------|------|--------|---------|58| Exosomes | 30-150 nm | MVB fusion | CD9, CD63, CD81 |59| Microvesicles | 100-1000 nm | Membrane budding | Annexin V, ARF6 |60| Apoptotic bodies | 500-5000 nm | Cell death | Annexin V, PS |61| Large oncosomes | 1-10 μm | Tumor-specific | Variable |6263## Workflow64651. **Input**: EV isolation method, cargo profiling data (RNA-seq, proteomics), characterization data.66672. **Quality Assessment**: Evaluate EV purity and characterization (NTA, TEM, markers).68693. **Cargo Analysis**: Profile RNA, protein, and lipid content.70714. **Source Deconvolution**: Identify tumor vs stromal EV origin.72735. **Biomarker Selection**: Identify cancer-specific signatures.74756. **Functional Prediction**: Predict effects on recipient cells.76777. **Output**: EV profile, biomarker candidates, functional predictions.7879## Example Usage8081**User**: "Analyze exosomal miRNA profiles from plasma samples to identify pancreatic cancer biomarkers."8283**Agent Action**:84```bash85python3 Skills/Oncology/Exosome_EV_Analysis_Agent/ev_analyzer.py \86 --ev_mirna exosome_smallrna.tsv \87 --ev_protein exosome_proteome.tsv \88 --sample_groups pancreatic_cancer,healthy \89 --normalization spike_in \90 --biomarker_discovery true \91 --output ev_biomarker_report/92```9394## Exosomal miRNA Cancer Biomarkers9596| Cancer Type | Elevated miRNAs | Clinical Use |97|-------------|-----------------|--------------|98| Pancreatic | miR-21, miR-17-5p, miR-155 | Early detection |99| Lung | miR-21, miR-126, miR-210 | Screening |100| Colorectal | miR-21, miR-92a, miR-29a | Detection |101| Prostate | miR-141, miR-375, miR-1290 | Prognosis |102| Ovarian | miR-21, miR-141, miR-200 family | Detection |103| Breast | miR-21, miR-155, miR-10b | Metastasis |104105## EV Isolation Methods106107| Method | Principle | Purity | Yield | Scalability |108|--------|-----------|--------|-------|-------------|109| Ultracentrifugation | Density | Moderate | High | Low |110| Size exclusion | Size | High | Moderate | Moderate |111| Immunocapture | Surface markers | Very high | Low | Low |112| Precipitation | Polymer | Low | Very high | High |113| Microfluidics | Various | Variable | Low | Low |114115## AI/ML Components116117**Biomarker Discovery**:118- Differential expression analysis119- Machine learning feature selection120- Multi-marker panel optimization121- Cross-validation and independent validation122123**Source Deconvolution**:124- Marker-based classification125- ML models for tumor vs normal EVs126- Cell-type specific cargo signatures127128**Functional Prediction**:129- miRNA target prediction130- Pathway enrichment131- Recipient cell effect modeling132133## EV Characterization Quality134135**MISEV Guidelines Requirements**:136- Particle concentration (NTA/TRPS)137- Size distribution (NTA/DLS/TEM)138- Protein markers (CD9/63/81, TSG101, ALIX)139- Negative markers (calnexin, albumin)140- Morphology (TEM)141142## Clinical Applications1431441. **Early Detection**: Cancer screening from blood EVs1452. **Prognosis**: EV signatures predicting outcomes1463. **Therapy Response**: Monitor treatment effect1474. **Metastasis**: Predict metastatic potential1485. **Resistance**: Identify resistance mechanisms149150## Prerequisites151152* Python 3.10+153* Small RNA analysis tools154* Proteomics analysis packages155* ML frameworks (scikit-learn, XGBoost)156157## Related Skills158159* Liquid_Biopsy_Analytics_Agent - For other liquid biopsy analytes160* Tumor_Microenvironment - For TME communication161* Cell-Free RNA Analysis - For plasma RNA162163## Emerging Applications1641651. **EV-based Drug Delivery**: Therapeutic cargo loading1662. **EV Engineering**: Surface modification for targeting1673. **Tumor Vaccines**: EV-based immunotherapy1684. **Companion Diagnostics**: Treatment selection markers169170## Author171172AI Group - Biomedical AI Platform173174175<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->